In July 2002, Aranesp was for the treatment of for the treatment of chemotherapy-induced anemia in patients with non-myeloid malignancies.. About Aranesp Aranesp is a recombinant erythropoietic protein . Amgen revolutionized the treatment of anemia associated with the development of recombinant erythropoietin, epoetin alfa. Building on this heritage, Amgen developed Aranesp, a unique erythropoiesis stimulating protein, the two additional carbohydrate chains containing sialic acid compared to the epoetin alfa molecule and remain longer in the bloodstream as epoetin alfa, because it has a longer half-life contains. Aranesp was by the U.S. Food and Drug Administration in September 2001 for the treatment of anemia associated with chronic renal failure, also known as chronic kidney disease , announced for patients on dialysis and patients not on dialysis approved.

About the Phase 2 Data Presented at ESCThis one-year study enrolled 319 patients with symptomatic heart failure , left ventricular ejection fraction of less than or equal to 40 % and Hb levels of 9 , 0 to 12.5 g / dL who were randomized to placebo or Aranesp to receive. Endpoints were the change in exercise time , NYHA class, Minnesota Living with Heart Failure Questionnaire score at 6 months, heart failure hospitalization and mortality at one year and security.‘ ‘It might be possible to to save the cells are in the a cell library and transplant them into your eyes or on the cells of one person to make use of their own eyes. ‘.. If testing in the rat model with infected retinal, the cells are migration the retina and adopted the characteristics of the surrounding neuron. Which researchers are now with In developing this approach for application of the human eye. Next to growing the cells in the lab and transplanting them returned into the eye of, the scientists are to stimulate growth to stimulate growth and persuade the eyes to repair itself using own cell. ‘Muller cell to stem cell properties could restoring sights of losing someone, and have lost her eyesight due diseased or damaged retina of,’says Dr.

Research at UCL Institute of Ophthalmology and Moorfields Eye Hospital have this Muller glia in the the eyes of the human studied by 18 months ago alt to 91 years. For research through the Wellcome Trust, the Medical Research Council and to the Helen Hamlyn Trust shown financing, the team found that is a population those cells are stem features and have able to probable in a range of different cells of the retina. The researchers were able which cells at vitro in every types of neurons on the retina develop into.